Please login to the form below

priority access

This page shows the latest priority access news and features for those working in and with pharma, biotech and healthcare.

Abivax’s COVID-19 study declared Research National Priority by French government

Those clinical trials, including Abivax’s study, that are declared to be a national priority gain access to an accelerated regulatory review and approval process by the French regulatory authorities (ASNM) ... AGE trial with ABX464 drug candidate a

Latest news

WHO says 172 countries are poised to participate in COVID-19 vaccine initiative

It is the only global initiative working with governments and manufacturers to ensure equitable access to COVID-19 vaccines. ... vulnerability, with front-line health and social care workers to be given priority.
The NHS is facing shortages of lifesaving treatments, says internal document

The document also apparently told doctors that certain patients would need to have priority over others for access to lifesaving drugs. Recommendations for rationing in the document included breaking tablets in ... You may wish to consider the following
NHS England says yes to Roche's Hemlibra

which has ensured access to emicizumab for patients with inhibitors with limited treatment options.”. ... Hemlibra's market access was agreed outside the normal framework of NHS England's specialised commissioning, which ranks treatments and procedures
Amgen gets prevention claim for cholesterol drug Repatha

Amgen CEO Robert Bradway said a few weeks ago that “improving patient access to Repatha remains a top priority for our team”, adding that the cardiovascular outcomes data will be a ... With this approval, it's now more important than ever that
GSK tops Access to Medicines Index for fifth time running

Only 5% of products covered by pricing strategies currently meet affordability criteria in priority access countries, according to the 2016 Index, despite companies increasingly waiving patent rights in priority regions. ... The Access to Medicines Index

More from news
Approximately 1 fully matching, plus 14 partially matching documents found.

Latest Intelligence

Building BRICs: pharma's key emerging markets are becoming giants

Further, the inference that locally-produced drugs may gain preferential access to state reimbursement lists has provided an added incentive for international manufacturers to invest in Russian infrastructure. ... Improving access to healthcare remains a

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Healthcare Senior Account Manager: Competitive

Sales Director, Healthcare communications agency, London/ SE UK: Six figure salary

Medical Editor: Competitive

Healthcare Lead Copywriter: Competitive

Account Director – Creative Healthcare Communications: Competative

Commercial Finance Director, Healthcare Marketing Communications...: up to £90K

Account Manager Healthcare / Pharmaceutical Sector: Negotiable Salary

Healthcare Account Director: Competitive

PMHub

Add my company

Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

Mistrust in medical research: a patient perspective: The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease: Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients: We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...